ONE-WAYOngoing theme · still written in the latest filings
Development of research reagents comprising HTLV-1- and ATL-related antibodies and assay systems
An individual product development program to develop antibodies and assay systems targeting HTLV-1-infected cells and ATL-related proteins, with the aim of selling them as research reagents.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.